These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 10856553

  • 1. Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapy.
    Ben-Ari Z, Mor E, Shaharabani E, Bar-Nathan N, Shapira Z, Tur-Kaspa R.
    Transplant Proc; 2000 Jun; 32(4):709-10. PubMed ID: 10856553
    [No Abstract] [Full Text] [Related]

  • 2. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A, Shaharabani E, Mor E, Lustig S, Bar-Nathan N, Shmueli D, Sobolev V, Dorfman B, Or H, Shapira Z.
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract] [Full Text] [Related]

  • 3. [Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation].
    Arnold JC, Theilmann L.
    Z Gastroenterol; 1995 Oct; 33(10):624-5. PubMed ID: 7502559
    [No Abstract] [Full Text] [Related]

  • 4. FK 506 rescue therapy for intractable liver allograft rejection.
    Wong P, Devlin J, Gane E, Ramage J, Portmann B, Williams R.
    Transpl Int; 1994 Oct; 7 Suppl 1():S70-6. PubMed ID: 11271339
    [Abstract] [Full Text] [Related]

  • 5. Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.
    Bechstein WO, Neuhaus P, McMaster P, Calne R, Pichlmayr R, Otto G, Williams R, Ericzon BG, Bismuth H.
    Transplant Proc; 1996 Apr; 28(2):1008-10. PubMed ID: 8623211
    [No Abstract] [Full Text] [Related]

  • 6. Long-term comparison of tacrolimus versus cyclosporine in liver transplantation. The US FK Study Group.
    Wiesner RH.
    Transplant Proc; 1998 Jun; 30(4):1399-400. PubMed ID: 9636565
    [No Abstract] [Full Text] [Related]

  • 7. Tacrolimus to rescue refractory hepatic allograft rejection: a collaborative study in Taiwan.
    Hung CM, Jeng LB, Yeh CN, Hsieh CH, Lee WC, Chen MF.
    Transplant Proc; 1998 Nov; 30(7):3589. PubMed ID: 9838572
    [No Abstract] [Full Text] [Related]

  • 8. Usefulness of the switch to tacrolimus in liver transplantation.
    González-Pinto I, Alonso O, Loinaz C, Gómez R, Rodríguez-Cañete A, Rodríguez F, Pérez-Saborido B, Paseiro G, Moreno-González E.
    Transplant Proc; 1999 Sep; 31(6):2425-6. PubMed ID: 10500653
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients.
    Platz KP, Tullius SG, Mueller AR, Schumacher G, Nüssler N, Neuhaus R, Bechstein WO, Lobeck H, Neuhaus P.
    Transplant Proc; 1996 Dec; 28(6):3183-4. PubMed ID: 8962235
    [No Abstract] [Full Text] [Related]

  • 11. Conversion to neoral provides effective rescue therapy for liver and kidney transplant patients intolerant of Prograf.
    Abouljoud M, Kumar MS, Brayman K, Emre S, Bynon SJ.
    Transplant Proc; 2001 Dec; 33(1-2):1027-8. PubMed ID: 11267175
    [No Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil rescue therapy in patients with chronic hepatic allograft rejection.
    Kato T, Ruiz P, DeFaria W, Weppler D, Khan F, Pinna A, Nery J, Tzakis A.
    Transplant Proc; 1999 Dec; 31(1-2):396. PubMed ID: 10083158
    [No Abstract] [Full Text] [Related]

  • 13. FK 506 rescue therapy in liver transplant recipients with drug-resistant rejection.
    Lewis WD, Jenkins RL, Burke PA, Winn KM, Shaffer D, Lopez R, Monaco AP.
    Transplant Proc; 1991 Dec; 23(6):2989-91. PubMed ID: 1721336
    [No Abstract] [Full Text] [Related]

  • 14. FK 506 and mycofenolate mofetil rescue for acute steroid-resistant and chronic rejection after liver transplantation.
    Platz KP, Mueller AR, Neuhaus R, Keck HH, Lobeck H, Neuhaus P.
    Transplant Proc; 1997 Nov; 29(7):2872-4. PubMed ID: 9365598
    [No Abstract] [Full Text] [Related]

  • 15. Neoral is superior to FK 506 in liver transplantation.
    Levy GA.
    Transplant Proc; 1998 Aug; 30(5):1812-5. PubMed ID: 9723293
    [No Abstract] [Full Text] [Related]

  • 16. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
    Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):641-3. PubMed ID: 7679828
    [No Abstract] [Full Text] [Related]

  • 17. Conversion from cyclosporine to FK 506 as rescue therapy in renal transplantation with poorly steroid-responsive acute rejection.
    Morales E, Andrés A, Herrero JC, Dominguez-Gil B, Carreño A, Morales JM, Hernández E, Ortuño T, Praga M.
    Transplant Proc; 1999 Sep; 31(6):2248-9. PubMed ID: 10500562
    [No Abstract] [Full Text] [Related]

  • 18. Tacrolimus versus cyclosporin microemulsion in liver transplantation: results of a 3-month study.
    Mühlbacher F, European Liver Transplantation Tacrolimus vs Cyclosporin Microemulsion Study Group.
    Transplant Proc; 2001 Sep; 33(1-2):1339-40. PubMed ID: 11267317
    [No Abstract] [Full Text] [Related]

  • 19. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
    Ichikura H, Tanabe K, Tokumoto T, Shimuzu T, Ishikawa N, Harano M, Inui M, Manu M, Ito S, Shimmura H, Okuda H, Yagisawa T, Fuchinoue S, Toma H.
    Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911
    [No Abstract] [Full Text] [Related]

  • 20. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J.
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.